Physician profile
Sy Tsi
NPI 1194743864
$9,851.93
in general payments reported to CMS, 2019-2025
51 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $986 · 2021: $1,772 · 2022: $1,475 · 2023: $1,403 · 2024: $1,352 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,326 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,325.66 |
| Education | $234.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,109.14 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $883.80 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $860.90 | 2019-2025 | Erleada, Balversa, Akeega |
| Coloplast Corp | $798.28 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $663.59 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $513.16 | 2023-2025 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $498.27 | 2021-2022 | |
| Abbvie INC. | $401.44 | 2019-2025 | Botox |
| Verity Pharmaceuticals INC. | $328.72 | 2022-2025 | Trelstar |
| Endo Pharmaceuticals INC. | $315.20 | 2019-2023 | Aveed, Xiaflex |
| Urogen Pharma, INC. | $297.30 | 2022-2025 | |
| Boston Scientific Corporation | $272.24 | 2019-2025 | Spaceoar System, Rezum Generator, Bulkamid |
| Laborie Medical Technologies Corp. | $210.81 | 2022 | |
| Teleflex LLC | $202.60 | 2021-2025 | Urolift, Barrigel |
| Caldera Medical, INC | $147.76 | 2021 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sy Tsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.